Zeo ScientifiX ZEOX
OTC ZEOX
$1.25 +0.05 (+4.17%)
At close: Oct 2, 2026 · 4:00 PM EDT

Zeo ScientifiX (ZEOX) Return on Capital Employed [ROCE] (2013 - 2026)

Updated

Zeo ScientifiX (ZEOX) reported Return on Capital Employed [ROCE] of -3514.04% for fiscal Q2 2026 (quarter ended Apr 30, 2026).

Analysis

Zeo ScientifiX (ZEOX) Return on Capital Employed [ROCE] (2013 - 2026) Analysis & Trends

For FY2023 (ended Oct 31, 2023), Zeo ScientifiX posted Return on Capital Employed [ROCE] of -1406.06%, up 239776.54 percentage points from FY2022.

  • By fiscal year, Return on Capital Employed [ROCE] came in at -241182.60% in FY2022.
  • The fiscal Q2 2026 figure ranks as the highest quarterly Return on Capital Employed [ROCE] since fiscal Q2 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 Zeo ScientifiX 9.73 Mn 6.32 Mn 2.06 Mn -3,514.04%
Historic Data

Historic Data

Download Data
DateValue
Apr 30, 2026 -3,514.04%
Apr 30, 2023 -1,846.86%
Jan 31, 2023 -511.47%
Oct 31, 2022 -2,797.63%
Apr 30, 2013 68.76%
Jan 31, 2013 2,452.48%
API Access

Zeo ScientifiX Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=ZEOX&period=max&api_key=YOUR_API_KEY